厄达替尼 Erdafitinib (Everest)
厄达替尼是一种口服药物，用于治疗携带特定基因突变的尿路上皮癌患者。
- The description claims that it is used for patients with locally advanced or metastatic urothelial carcinoma with FGFR2 or FGFR3 gene mutations.
Specifications
- 通用名称
- Erdafitinib, 厄达替尼
- 剂型
- 片剂
- 剂量
- 4mg
AI Readiness
Good foundation, but some important product data is still missing.
69%